Carzo, Analyn R.
HRN: 16-28-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/03/2024
02/10/2024
IV
500mg
Q8
Exla AP
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes